Medicine
Elepsia XR 1500 MG 1500 mg extended-release tablet
Elepsia XR 1500 MG 1500 mg extended-release tablet is a prescription medicine containing Levetiracetam for oral use, marketed by Tripoint Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and…
Key facts
- Active ingredient (INN)
- Levetiracetam
- Brand
- Elepsia XR 1500 MG
- Strength
- 1500 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 1 blister pack, 30 tablets
- Marketing authorisation holder
- Tripoint Therapeutics
- Manufacturer
- Tripoint Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N03AX14 Levetiracetam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 February 2021
- Identifiers
- RxCUI 1605362, 1605368, 1605372 +1DailyMed set ID cac83d47-88a2-4447-a0c0-90b44ffda0acNDC 80705-101Application NDA204417
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 carton / 2 tablet, extended release in 1 blister pack | 80705-101-02 | Tripoint Therapeutics | 29 September 2021 |
| 30 tablet, extended release in 1 bottle, plastic | 80705-101-30 | Tripoint Therapeutics | 12 February 2021 |
| 1 blister pack in 1 carton / 7 tablet, extended release in 1 blister pack | 80705-101-99 | Tripoint Therapeutics | 12 February 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Levetiracetam
Clinical summary
Levetiracetam is a prescription medicine indicated for the treatment of partial-onset seizures in patients 1 month of age and older, among other approved uses. MedsAcross supplies Levetiracetam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LevetiracetamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Keppra prescribing information (UCB) · U.S. National Library of Medicine, DailyMed
- Keppra: European public assessment report (EPAR) · European Medicines Agency
- Levetiracetam Accord: European public assessment report (EPAR) · European Medicines Agency
Need Elepsia XR 1500 MG 1500 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.